Apolipoproteins E and AV mediate lipoprotein clearance by hepatic proteoglycans

Por Gonzales, Jon C., Gordts, Philip L.S.M., Foley, Erin M., Esko, Jeffrey D.
Publicado em 2013

Small molecule antagonists of cell-surface heparan sulfate and heparin–protein interactions

Por Weiss, Ryan J., Gordts, Philip L. S. M., Le, Dzung, Xu, Ding, Esko, Jeffrey D., Tor, Yitzhak
Publicado no Chem Sci (2015)

A Genetic Model of Substrate Reduction Therapy for Mucopolysaccharidosis

Por Lamanna, William C., Lawrence, Roger, Sarrazin, Stéphane, Lameda-Diaz, Carlos, Gordts, Philip L. S. M., Moremen, Kelley W., Esko, Jeffrey D.
Publicado em 2012

Hepatic Remnant Lipoprotein Clearance by Heparan Sulfate Proteoglycans and Low-Density Lipoprotein Receptors Depend on Dietary Conditions in Mice

Por Foley, Erin M., Gordts, Philip L.S.M., Stanford, Kristin I., Gonzales, Jon C., Lawrence, Roger, Stoddard, Nicole, Esko, Jeffrey D.
Publicado em 2013

Impaired LDL Receptor-Related Protein 1 Translocation Correlates with Improved Dyslipidemia and Atherosclerosis in apoE-Deficient Mice

Por Gordts, Philip L.S.M., Bartelt, Alexander, Nilsson, Stefan K., Annaert, Wim, Christoffersen, Christina, Nielsen, Lars Bo, Heeren, Joerg, Roebroek, Anton J.M.
Publicado em 2012

The plasma concentration of HDL-associated apoM is influenced by LDL receptor-mediated clearance of apoB-containing particles

Por Christoffersen, Christina, Benn, Marianne, Christensen, Pernille M., Gordts, Philip L. S. M., Roebroek, Anton J. M., Frikke-Schmidt, Ruth, Tybjaerg-Hansen, Anne, Dahlbäck, Björn, Nielsen, Lars B.
Publicado em 2012

Reducing Macrophage Proteoglycan Sulfation increases Atherosclerosis and Obesity through Enhanced Type I Interferon Signaling

Por Gordts, Philip L.S.M., Foley, Erin, Lawrence, Roger, Sinha, Risha, Lameda-Diaz, Carlos, Deng, Liwen, Nock, Ryan, Glass, Christopher K., Erbilgin, Ayca, Lusis, Aldons J., Witztum, Joseph L., Esko, Jeffrey D.
Publicado no Cell Metab (2014)

ApoC-III inhibits clearance of triglyceride-rich lipoproteins through LDL family receptors

Por Gordts, Philip L.S.M., Nock, Ryan, Son, Ni-Huiping, Ramms, Bastian, Lew, Irene, Gonzales, Jon C., Thacker, Bryan E., Basu, Debapriya, Lee, Richard G., Mullick, Adam E., Graham, Mark J., Goldberg, Ira J., Crooke, Rosanne M., Witztum, Joseph L., Esko, Jeffrey D.
Publicado no J Clin Invest (2016)

Brown fat activation reduces hypercholesterolaemia and protects from atherosclerosis development

Por Berbée, Jimmy F. P., Boon, Mariëtte R, Khedoe, P. Padmini S. J., Bartelt, Alexander, Schlein, Christian, Worthmann, Anna, Kooijman, Sander, Hoeke, Geerte, Mol, Isabel M., John, Clara, Jung, Caroline, Vazirpanah, Nadia, Brouwers, Linda P.J., Gordts, Philip L.S.M., Esko, Jeffrey D., Hiemstra, Pieter S., Havekes, Louis M., Scheja, Ludger, Heeren, Joerg, Rensen, Patrick C.N.
Publicado no Nat Commun (2015)

Ext1 heterozygosity causes a modest effect on postprandial lipid clearance in humans

Por Mooij, Hans L., Bernelot Moens, Sophie J., Gordts, Philip L. S. M., Stanford, Kristin I., Foley, Erin M., van den Boogert, Marjolein A. W., Witjes, Julia J., Hassing, H. Carlijne, Tanck, Michael W., van de Sande, Michiel A. J., Levels, J. Han, Kastelein, John J. P., Stroes, Erik S. G., Dallinga-Thie, Geesje M., Esko, Jeff D., Nieuwdorp, Max
Publicado no J Lipid Res (2015)